Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect

This publication has 28 references indexed in Scilit:

• Impaired cellular immune function in patients with end-stage renal failure
  Nephrology Dialysis Transplantation, 1999
• CD80, CD86 and CD40 Provide Accessory Signals in a Multiple‐Step T‐Cell Activation Model
  Immunological Reviews, 1996
• Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure
  American Journal of Kidney Diseases, 1995
• Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
  Immunity, 1994
• Functional characterization of a novel anti‐B7 monoclonal antibody
  European Journal of Immunology, 1992
• CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation.
  The Journal of Experimental Medicine, 1992
• Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway
  Cellular Immunology, 1991
• Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure
  Kidney International, 1990
• In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients
  Kidney International, 1989
• Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.
  Journal of Clinical Investigation, 1987